VTYX 241115 7.50P (VTYX241115P7500) Stock Options, News & Quotes

Account Info

Log Out

US OptionsDetailed Quotes

VTYX241115P7500

Watchlist

0.00
0.000.00%

15min DelayClose Nov 6 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Express News | Watching Regulus Therapeutics; Shares See Volume To The Upside As Traders Circulate TipRanks Article Titled 'These 2 'Strong Buy' Penny Stocks Could Rally Over 500%, Say Analysts'
BenzingaOct 28 11:22 ET
Ventyx Biosciences' Tamuzimod: Promising Data but Insufficient for Upgrade Beyond Hold
TipRanksOct 15 11:45 ET · Ratings
Express News | Ventyx Biosciences Presents New 52-Week Results From the Phase 2 Trial of Vtx002 (Tamuzimod) in Ulcerative Colitis at Ueg Week 2024
ReutersOct 15 08:00 ET
Ventyx Biosciences Presents New 52-Week Results From the Phase 2 Trial of VTX002 (Tamuzimod) in Ulcerative Colitis at UEG Week 2024
GlobeNewswireOct 15 08:00 ET
Oppenheimer Maintains Ventyx Biosciences(VTYX.US) With Buy Rating, Maintains Target Price $10
Moomoo NewsSep 24 08:31 ET · Ratings
LifeSci Capital Maintains Ventyx Biosciences(VTYX.US) With Buy Rating
Moomoo NewsSep 23 22:31 ET · Ratings

Comments

Jaguar8

Oct 15 08:03

NEWS

$Ventyx Biosciences (VTYX.US)$
Ventyx Biosciences Presents New 52-Week Results from the Phase 2 Trial of VTX002 (Tamuzimod) in Ulcerative Colitis at UEG Week 2024
Ventyx Biosciences (Nasdaq: VTYX) presented new 52-week results from the Phase 2 trial of VTX002 (tamuzimod) in ulcerative colitis at UEG Week 2024. The late-breaking abstract highlighted high rates of clinical and endoscopic remission among long-term extension (LTE) completers at Week 52. CEO Raju Mohan emphasized the data's reinfo...

Jaguar8

Sep 23 12:35

Ventyx Biosciences Price Target Maintained With a $6.00/Share by HC Wainwright & Co

$Ventyx Biosciences (VTYX.US)$

Stock_Drift

Sep 23 08:00

9/23/24 👀’s on_watchlist. 🚨🚨*not financial advice*

$Nuvve (NVVE.US)$ $Treasure Global (TGL.US)$ $Expion360 (XPON.US)$ $Black Diamond Therapeutics (BDTX.US)$ $Ventyx Biosciences (VTYX.US)$
📊⚡️📊

Jaguar8

Sep 23 07:26

“Sanofi has agreed to make a $27 million strategic investment in the Company at an as-converted price of $3.8243 per share of common stock”

$Ventyx Biosciences (VTYX.US)$

Jaguar8

Sep 23 07:03

NEWS

$Ventyx Biosciences (VTYX.US)$
Ventyx Biosciences Announces $27 Million Strategic Investment from Sanofi
SAN DIEGO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (NASDAQ:VTYX) ("Ventyx"), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that Sanofi has agreed to make a $27 million strategic investment in the Company at an as-converted price...